Back to Report

Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

  • Published: May-2018
  • Report Code: GBIHC475MR
  • Report Format: pdf
Email to a colleague
Enquiry Before Buying
      captcha refresh
     

I have read and accept terms and conditions and privacy policy

Cancel
 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
 
      captcha refresh
     

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards